Neovascular AMD: what to do today
Tue 12 Jul
|IEMO VideoPodcast
This episode gives a 360-degree view on the issue of neovascular AMD, regarding treatment regimens, biomarkers and the role of OCT; also addressing the debate on fluid tolerance. Specific characteristics of the various anti-VEGF drugs currently in use will be also widely discussed.
Time & Location
12 Jul 2022, 15:00
IEMO VideoPodcast
About the event
Moderator: Prof. Paolo Lanzetta
Guests: Prof. Francesco Boscia, Prof. Diego Fornasari
In this episode, Prof. Paolo Lanzetta, Prof. Francesco Boscia and Prof. Diego Fornasari present a 360-degree view on the issue of age-related macular degeneration complicated by choroidal neovascularization. They will discuss the importance of treatment regimens, biomarkers during the monitoring and planning of reprocessing, the role of OCT and OCT angiography. They will compare different points of view in the tolerance and management of fluid from different retinal perspectives and give a broad explanation regarding specific characteristics of different anti-VEGF drugs that are currently in use for the management of the disease.
The event is not valid for ECM purposes.
